Robert Gelein
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Inhalation Exposure | 10 | 1995 | 22 |
Why?
| Lung | 15 | 1996 | 232 |
Why?
| Air Pollutants | 9 | 1995 | 42 |
Why?
| Environmental Pollutants | 2 | 2005 | 35 |
Why?
| Methylmercury Compounds | 2 | 2005 | 25 |
Why?
| Rats | 31 | 1969 | 530 |
Why?
| Lipopolysaccharides | 8 | 1998 | 98 |
Why?
| Vehicle Emissions | 3 | 1996 | 14 |
Why?
| Animal Feed | 1 | 2005 | 11 |
Why?
| Carbon | 6 | 2000 | 30 |
Why?
| Rats, Inbred F344 | 18 | 1992 | 80 |
Why?
| Food Contamination | 1 | 2005 | 18 |
Why?
| Ozone | 5 | 2000 | 18 |
Why?
| Cytokines | 9 | 1996 | 207 |
Why?
| Animals, Newborn | 8 | 1996 | 175 |
Why?
| Nanoparticles | 3 | 2006 | 13 |
Why?
| Animals | 43 | 1969 | 1031 |
Why?
| Administration, Inhalation | 14 | 1997 | 60 |
Why?
| Particle Size | 13 | 1992 | 55 |
Why?
| Polytetrafluoroethylene | 5 | 1995 | 23 |
Why?
| Bronchoalveolar Lavage Fluid | 11 | 1998 | 68 |
Why?
| Methanol | 2 | 1996 | 15 |
Why?
| Aerosols | 7 | 1995 | 39 |
Why?
| Pneumonia | 4 | 2002 | 85 |
Why?
| Chemokines | 4 | 1998 | 48 |
Why?
| Neutrophils | 9 | 1992 | 114 |
Why?
| Strontium Radioisotopes | 1 | 1997 | 5 |
Why?
| Titanium | 5 | 1992 | 36 |
Why?
| Macrophages, Alveolar | 4 | 1992 | 44 |
Why?
| Aging | 4 | 2000 | 275 |
Why?
| Lung Diseases | 4 | 1995 | 112 |
Why?
| Male | 31 | 1969 | 1553 |
Why?
| Maternal Exposure | 1 | 1996 | 24 |
Why?
| Clodronic Acid | 2 | 2004 | 12 |
Why?
| Developmental Disabilities | 1 | 1996 | 54 |
Why?
| Rats, Long-Evans | 3 | 1996 | 19 |
Why?
| Disease Models, Animal | 3 | 1995 | 349 |
Why?
| L-Lactate Dehydrogenase | 3 | 1988 | 59 |
Why?
| Iron | 2 | 2005 | 75 |
Why?
| Toxicity Tests | 2 | 2004 | 17 |
Why?
| Brain | 4 | 1996 | 305 |
Why?
| Endotoxins | 2 | 2000 | 35 |
Why?
| Iron, Dietary | 1 | 2011 | 5 |
Why?
| Oxidants, Photochemical | 2 | 2000 | 9 |
Why?
| Dose-Response Relationship, Drug | 8 | 1992 | 431 |
Why?
| Fetal Development | 1 | 2011 | 13 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2010 | 46 |
Why?
| RNA, Messenger | 10 | 1998 | 394 |
Why?
| Silicon Dioxide | 3 | 1997 | 27 |
Why?
| Siloxanes | 2 | 1998 | 9 |
Why?
| Mice | 15 | 1998 | 623 |
Why?
| Electrochemical Techniques | 1 | 2010 | 3 |
Why?
| Nanotubes, Carbon | 1 | 2010 | 5 |
Why?
| Chemokines, CC | 2 | 2000 | 15 |
Why?
| Metal Nanoparticles | 1 | 2010 | 10 |
Why?
| Lung Injury | 1 | 2009 | 36 |
Why?
| Mercury | 1 | 2010 | 25 |
Why?
| Pseudomonas aeruginosa | 2 | 2000 | 33 |
Why?
| Oxygen | 3 | 1969 | 179 |
Why?
| Mice, Inbred C57BL | 8 | 1998 | 318 |
Why?
| Pulmonary Surfactants | 1 | 2009 | 35 |
Why?
| Soot | 1 | 2006 | 3 |
Why?
| Pulmonary Alveoli | 1 | 2009 | 80 |
Why?
| Genes, Immediate-Early | 1 | 2006 | 10 |
Why?
| Manganese Compounds | 1 | 2006 | 8 |
Why?
| Autonomic Nervous System | 1 | 2007 | 41 |
Why?
| Oxides | 1 | 2006 | 21 |
Why?
| Chlorodiphenyl (54% Chlorine) | 1 | 2005 | 2 |
Why?
| Reactive Oxygen Species | 5 | 2000 | 112 |
Why?
| Oxidoreductases | 1 | 2006 | 41 |
Why?
| Control Groups | 1 | 2005 | 2 |
Why?
| Fish Products | 1 | 2005 | 8 |
Why?
| Confounding Factors (Epidemiology) | 1 | 2005 | 49 |
Why?
| Antimetabolites | 1 | 2005 | 21 |
Why?
| Heme Oxygenase-1 | 1 | 2005 | 28 |
Why?
| Models, Biological | 1 | 2011 | 410 |
Why?
| Central Nervous System | 1 | 2006 | 77 |
Why?
| Female | 11 | 1996 | 1643 |
Why?
| Fracture Healing | 1 | 2005 | 23 |
Why?
| Blood Pressure | 1 | 2007 | 205 |
Why?
| Pregnancy | 4 | 1996 | 455 |
Why?
| Dopamine | 1 | 2005 | 62 |
Why?
| Diet | 1 | 2005 | 87 |
Why?
| Gases | 1 | 2004 | 23 |
Why?
| Monokines | 2 | 2000 | 20 |
Why?
| Inflammation | 3 | 2000 | 208 |
Why?
| Tissue Distribution | 4 | 2002 | 124 |
Why?
| Hypertension | 1 | 2007 | 161 |
Why?
| Lead | 1 | 2005 | 55 |
Why?
| Time Factors | 6 | 1973 | 896 |
Why?
| Estrogens, Non-Steroidal | 1 | 2002 | 7 |
Why?
| Skin Absorption | 1 | 2002 | 10 |
Why?
| Kidney | 3 | 1988 | 223 |
Why?
| Fluorides | 3 | 1988 | 35 |
Why?
| Injections, Intraperitoneal | 5 | 1969 | 57 |
Why?
| Gene Expression Regulation | 1 | 2006 | 277 |
Why?
| Copper | 2 | 2010 | 36 |
Why?
| Mutagens | 1 | 2000 | 29 |
Why?
| Liver | 2 | 1998 | 248 |
Why?
| Nitrogen Dioxide | 1 | 2000 | 9 |
Why?
| Metallothionein | 4 | 1998 | 23 |
Why?
| Instillation, Drug | 2 | 1992 | 9 |
Why?
| Fetus | 2 | 1996 | 105 |
Why?
| Uranium Compounds | 2 | 1988 | 4 |
Why?
| Uranium | 2 | 1988 | 5 |
Why?
| Uteroglobin | 1 | 1999 | 12 |
Why?
| Immune Tolerance | 1 | 2000 | 72 |
Why?
| Blotting, Western | 3 | 1999 | 275 |
Why?
| Specific Pathogen-Free Organisms | 3 | 2000 | 26 |
Why?
| Cell Count | 3 | 2000 | 163 |
Why?
| Neurons | 1 | 2005 | 195 |
Why?
| Fibronectins | 1 | 1999 | 57 |
Why?
| Proteins | 2 | 1992 | 192 |
Why?
| Immunoenzyme Techniques | 2 | 2006 | 125 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1996 | 9 |
Why?
| Rats, Sprague-Dawley | 2 | 2010 | 257 |
Why?
| Mental Processes | 1 | 1996 | 10 |
Why?
| Toluene | 1 | 1996 | 13 |
Why?
| Mesocricetus | 2 | 2005 | 17 |
Why?
| Trachea | 1 | 1997 | 50 |
Why?
| Air Pollution, Indoor | 1 | 1996 | 15 |
Why?
| Age Factors | 3 | 2000 | 480 |
Why?
| Drug Evaluation, Preclinical | 1 | 1996 | 65 |
Why?
| Rats, Inbred SHR | 2 | 2004 | 24 |
Why?
| Olfactory Bulb | 2 | 2004 | 15 |
Why?
| Mice, Inbred Strains | 2 | 2005 | 118 |
Why?
| Biological Markers | 2 | 2006 | 262 |
Why?
| Cells, Cultured | 3 | 2000 | 447 |
Why?
| Gestational Age | 1 | 1996 | 114 |
Why?
| Cricetinae | 2 | 2005 | 130 |
Why?
| Occupational Exposure | 1 | 1996 | 53 |
Why?
| Air Pollution | 1 | 1995 | 17 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 2 | 2000 | 13 |
Why?
| Mortality | 1 | 1995 | 50 |
Why?
| Analysis of Variance | 3 | 1996 | 339 |
Why?
| Kidney Diseases | 2 | 1989 | 90 |
Why?
| Pneumoconiosis | 1 | 1992 | 6 |
Why?
| Organ Size | 3 | 1988 | 118 |
Why?
| NAD | 2 | 1970 | 41 |
Why?
| Silver | 1 | 2011 | 8 |
Why?
| Humans | 8 | 1995 | 1856 |
Why?
| Species Specificity | 2 | 2000 | 186 |
Why?
| Anemia, Iron-Deficiency | 1 | 2011 | 28 |
Why?
| Cochlear Nerve | 1 | 2011 | 9 |
Why?
| Bronchoalveolar Lavage | 2 | 2000 | 24 |
Why?
| Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 21 |
Why?
| Nuclease Protection Assays | 2 | 2000 | 4 |
Why?
| Chemokine CCL3 | 2 | 2000 | 9 |
Why?
| Neural Conduction | 1 | 2011 | 41 |
Why?
| Chemokine CCL11 | 2 | 2000 | 10 |
Why?
| Chemokine CCL4 | 2 | 2000 | 16 |
Why?
| Chemokine CXCL2 | 2 | 2000 | 29 |
Why?
| Macrophage Inflammatory Proteins | 2 | 2000 | 17 |
Why?
| Glucuronidase | 1 | 2010 | 26 |
Why?
| Gold | 1 | 2010 | 17 |
Why?
| Elastin | 1 | 2009 | 22 |
Why?
| Luciferases | 1 | 2010 | 70 |
Why?
| Oxidative Stress | 2 | 2000 | 119 |
Why?
| Respiratory Function Tests | 1 | 2009 | 72 |
Why?
| Respiratory Mechanics | 1 | 2009 | 30 |
Why?
| Body Weight | 2 | 1989 | 178 |
Why?
| RNA | 2 | 1996 | 126 |
Why?
| Nephrectomy | 1 | 1988 | 36 |
Why?
| Hyperbaric Oxygenation | 3 | 1969 | 5 |
Why?
| Nitric Oxide Synthase | 2 | 1996 | 44 |
Why?
| Interleukin-6 | 2 | 2000 | 145 |
Why?
| Interleukins | 2 | 1996 | 32 |
Why?
| Automobile Driving | 1 | 2007 | 19 |
Why?
| Telemetry | 1 | 2007 | 19 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2006 | 17 |
Why?
| Child | 1 | 1996 | 749 |
Why?
| Toll-Like Receptors | 1 | 2006 | 19 |
Why?
| Microscopy, Electron, Transmission | 1 | 2006 | 31 |
Why?
| Solubility | 1 | 2006 | 75 |
Why?
| Random Allocation | 1 | 2006 | 160 |
Why?
| Oligoribonucleotides, Antisense | 1 | 2005 | 3 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 35 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 28 |
Why?
| Chlorides | 1 | 2006 | 69 |
Why?
| Deferoxamine | 1 | 2005 | 16 |
Why?
| Body Burden | 2 | 1989 | 24 |
Why?
| Metalloporphyrins | 1 | 2005 | 8 |
Why?
| No-Observed-Adverse-Effect Level | 1 | 2005 | 6 |
Why?
| Protoporphyrins | 1 | 2005 | 14 |
Why?
| Peroxidase | 1 | 2005 | 27 |
Why?
| Drug Therapy, Combination | 1 | 2006 | 189 |
Why?
| Oxidation-Reduction | 1 | 2006 | 124 |
Why?
| Tibia | 1 | 2005 | 34 |
Why?
| Chondrogenesis | 1 | 2005 | 17 |
Why?
| Sodium Chloride | 1 | 2005 | 77 |
Why?
| Endpoint Determination | 1 | 2004 | 27 |
Why?
| Heart Rate | 1 | 2007 | 138 |
Why?
| Telencephalon | 1 | 2004 | 19 |
Why?
| Endothelin-2 | 1 | 2004 | 8 |
Why?
| Cartilage | 1 | 2005 | 33 |
Why?
| Leukocyte Count | 1 | 2004 | 94 |
Why?
| Liposomes | 1 | 2004 | 38 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 104 |
Why?
| Cerebellum | 1 | 2004 | 59 |
Why?
| Macrophage Activation | 1 | 2004 | 42 |
Why?
| Orthomyxoviridae | 1 | 2004 | 34 |
Why?
| Cell Survival | 1 | 2005 | 229 |
Why?
| Immunocompromised Host | 1 | 2004 | 70 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 1996 | 210 |
Why?
| Nerve Tissue Proteins | 1 | 2006 | 128 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 216 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 51 |
Why?
| Mass Spectrometry | 1 | 2002 | 57 |
Why?
| Administration, Cutaneous | 1 | 2002 | 22 |
Why?
| NF-kappa B | 1 | 2006 | 114 |
Why?
| Drug Synergism | 1 | 2002 | 104 |
Why?
| Transplantation, Heterologous | 1 | 2002 | 57 |
Why?
| Skin Transplantation | 1 | 2002 | 39 |
Why?
| Osteoclasts | 1 | 2005 | 48 |
Why?
| Mice, Nude | 1 | 2002 | 72 |
Why?
| Cell Proliferation | 1 | 2005 | 227 |
Why?
| Biological Transport | 1 | 2002 | 129 |
Why?
| Electrocardiography | 1 | 2007 | 132 |
Why?
| Pilot Projects | 1 | 2002 | 264 |
Why?
| Cell Line | 1 | 2005 | 375 |
Why?
| Luminescent Measurements | 1 | 2000 | 35 |
Why?
| Microscopy, Electron, Scanning | 1 | 2000 | 69 |
Why?
| Respiratory Burst | 1 | 2000 | 10 |
Why?
| In Situ Nick-End Labeling | 1 | 2000 | 65 |
Why?
| Chemokine CXCL10 | 1 | 2000 | 22 |
Why?
| Lung Diseases, Interstitial | 1 | 2000 | 11 |
Why?
| Mice, Inbred BALB C | 1 | 2002 | 176 |
Why?
| Pulmonary Emphysema | 1 | 2000 | 24 |
Why?
| Metals | 1 | 2000 | 35 |
Why?
| Atmospheric Pressure | 2 | 1969 | 6 |
Why?
| Metabolism | 2 | 1969 | 23 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2000 | 39 |
Why?
| Chemokines, CXC | 1 | 2000 | 32 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2000 | 83 |
Why?
| Glycosuria | 1 | 1999 | 8 |
Why?
| New York | 1 | 2004 | 422 |
Why?
| Kidney Function Tests | 1 | 1999 | 24 |
Why?
| Hybridization, Genetic | 1 | 1998 | 12 |
Why?
| Chemokine CCL2 | 1 | 2000 | 57 |
Why?
| Volatilization | 1 | 1998 | 9 |
Why?
| Ribonucleases | 1 | 1998 | 42 |
Why?
| Glomerular Filtration Rate | 1 | 1999 | 33 |
Why?
| Creatinine | 2 | 1988 | 69 |
Why?
| Heme Oxygenase (Decyclizing) | 1 | 2000 | 18 |
Why?
| Fluorescent Antibody Technique | 1 | 1999 | 164 |
Why?
| Atmosphere Exposure Chambers | 1 | 1996 | 14 |
Why?
| Aerospace Medicine | 1 | 1996 | 8 |
Why?
| Glucose | 2 | 1988 | 120 |
Why?
| Protein C | 1 | 1996 | 28 |
Why?
| Cross-Over Studies | 1 | 1996 | 82 |
Why?
| Endothelial Growth Factors | 1 | 1996 | 47 |
Why?
| Blotting, Northern | 1 | 1996 | 151 |
Why?
| Memory | 1 | 1996 | 61 |
Why?
| Double-Blind Method | 1 | 1998 | 274 |
Why?
| In Situ Hybridization | 1 | 1996 | 135 |
Why?
| Reaction Time | 1 | 1996 | 81 |
Why?
| Hot Temperature | 1 | 1995 | 93 |
Why?
| Succinates | 2 | 1969 | 6 |
Why?
| Motor Activity | 1 | 1995 | 104 |
Why?
| Adult | 2 | 1996 | 1317 |
Why?
| Extracellular Space | 1 | 1992 | 58 |
Why?
| Sulfhydryl Compounds | 1 | 1970 | 42 |
Why?
| Albuminuria | 1 | 1988 | 7 |
Why?
| Alanine Transaminase | 1 | 1988 | 20 |
Why?
| Seizures | 3 | 1969 | 79 |
Why?
| Middle Aged | 1 | 1998 | 1161 |
Why?
| Aminobutyric Acids | 2 | 1969 | 5 |
Why?
| Glutamates | 2 | 1969 | 29 |
Why?
| Malates | 2 | 1969 | 7 |
Why?
| Methods | 2 | 1969 | 133 |
Why?
| Glutathione | 2 | 1969 | 65 |
Why?
| Cysteine | 2 | 1969 | 52 |
Why?
| Disulfiram | 1 | 1973 | 4 |
Why?
| Dogs | 1 | 1973 | 159 |
Why?
| Cystine | 1 | 1969 | 7 |
Why?
| Oxidative Phosphorylation | 1 | 1970 | 19 |
Why?
| Sodium | 1 | 1969 | 96 |
Why?
|
|
Gelein's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
